The general quota of personal capital of
German middle classes is very low actually and according to experts it might
continue decreasing if business trends do not become inverted during the next
few years. At the moment there are no signs. Companies that do not comply with
the criteria of credit-worthiness in accordance with Basel II, and about one
quarter of all companies are concerned, also in the health care services, will
not receive any bank loans whatsoever in the future.
They will be threatened by closure and this again will have catastrophic repercussions
on the investment climate in Germany as well as on the (general) situation of
investment markets. Furthermore we are confronted with a continually growing demand
for risk capital both for trendsetting health care and for service projects which
cannot be financed by institutional investors.
We support appropriate projects in
refinancing, in classical new financing as well as in the acquisition of venture
capital and personal capital by means of the various instruments of private placement.
In this regard we are working on the solution of any problem and we are not limited
to the classical financial instruments for companies' financing. One of our basic
instruments in this area consists in an expert rating system, that means first we
compile and assess the fundamental data of a project.
We hereby are concentrated on our core business area of innovative health care and
service projects and we can fall back upon an international network of contacts